期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 22, 期 15, 页码 -出版社
MDPI
DOI: 10.3390/ijms22157900
关键词
microbiome; immunotherapy; immune checkpoint; toxicity; adverse events; lung cancer
资金
- University of Kansas Medical Center Start-up Funds
- Play with a Pro Lung Cancer Research Fund
- University of Kansas Cancer Center
The role of the microbiome in immunology is an increasingly important area of study, with research showing links between the microbiome and tumorigenesis, chemotherapy and radiation potentiation, as well as immune checkpoint inhibitor efficacy and immune-related adverse events.
The role of the microbiome in immunology is a rapidly burgeoning topic of study. Given the increasing use of immune checkpoint inhibitor (ICI) therapy in cancers, along with the recognition that carcinogenesis has been linked to dysregulations of the immune system, much attention is now directed at potentiation of ICI efficacy, as well as minimizing the incidence of treatment-associated immune-related adverse events (irAEs). We provide an overview of the major research establishing links between the microbiome to tumorigenesis, chemotherapy and radiation potentiation, and ICI efficacy and irAE development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据